Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator — Class II drug recall D-0175-2023
Terminated recall by Nephron Sc Inc, reported 2023-02-01, distributed nationwide. Short Fill
| Recall number | D-0175-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Nephron Sc Inc, West Columbia, SC, United States |
| Recall initiated | 2023-01-13 |
| Classified | 2023-01-23 |
| Reported by FDA | 2023-02-01 |
| Terminated | 2024-10-11 |
| Distributed | Nationwide (US) |
| Quantity | 387,000 vials |
| UPC / GTIN / UDI-DI | 00304872784014 |
| NDC | 00487-2784-01 |
| Lot numbers | 126451 |
| Expiration dates | 2023-04-30 |
Product
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
Reason for recall
Short Fill
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0175-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.